REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 134 filers reported holding REPLIMUNE GROUP INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,536 | -26.3% | 1,960 | 0.0% | 0.00% | – |
| Q2 2023 | $45,511 | +252738.9% | 1,960 | +88.6% | 0.00% | – |
| Q1 2023 | $18 | -35.7% | 1,039 | 0.0% | 0.00% | – |
| Q4 2022 | $28 | -99.9% | 1,039 | 0.0% | 0.00% | – |
| Q3 2022 | $19,000 | +11.8% | 1,039 | +3.9% | 0.00% | – |
| Q2 2022 | $17,000 | +183.3% | 1,000 | +233.3% | 0.00% | – |
| Q4 2021 | $6,000 | -33.3% | 300 | 0.0% | 0.00% | – |
| Q3 2021 | $9,000 | -25.0% | 300 | 0.0% | 0.00% | – |
| Q2 2021 | $12,000 | +33.3% | 300 | 0.0% | 0.00% | – |
| Q1 2021 | $9,000 | -82.0% | 300 | -76.9% | 0.00% | – |
| Q4 2020 | $50,000 | – | 1,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 5,344,971 | $122,395,000 | 33.11% |
| Corriente Advisors, LLC | 512,500 | $11,798,000 | 5.98% |
| Bain Capital Life Sciences Investors, LLC | 2,122,415 | $48,858,000 | 4.55% |
| BVF INC/IL | 1,691,834 | $38,946,000 | 2.12% |
| Redmile Group, LLC | 3,330,999 | $76,680,000 | 1.41% |
| EMERALD ADVISERS, LLC | 891,761 | $20,528,000 | 0.84% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 823,989 | $18,968,000 | 0.84% |
| Penn Mutual Asset Management, LLC | 15,877 | $365,000 | 0.52% |
| EAM Global Investors LLC | 54,274 | $1,249,000 | 0.46% |
| Artal Group S.A. | 700,000 | $16,114,000 | 0.39% |